These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15265562)

  • 41. Use of hydrophobins in formulation of water insoluble drugs for oral administration.
    Haas Jimoh Akanbi M; Post E; Meter-Arkema A; Rink R; Robillard GT; Wang X; Wösten HA; Scholtmeijer K
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):526-31. PubMed ID: 19836932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
    Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
    Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability.
    Miller MA; DiNunzio J; Matteucci ME; Ludher BS; Williams RO; Johnston KP
    Drug Dev Ind Pharm; 2012 May; 38(5):557-70. PubMed ID: 21961961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
    Shaikh J; Ankola DD; Beniwal V; Singh D; Kumar MN
    Eur J Pharm Sci; 2009 Jun; 37(3-4):223-30. PubMed ID: 19491009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A.
    Guan P; Lu Y; Qi J; Wu W
    Colloids Surf B Biointerfaces; 2016 Aug; 144():143-151. PubMed ID: 27085046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability.
    Kapse SV; Gaikwad RV; Samad A; Devarajan PV
    Int J Pharm; 2012 Jun; 429(1-2):104-12. PubMed ID: 22414426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery.
    Meissner Y; Pellequer Y; Lamprecht A
    Int J Pharm; 2006 Jun; 316(1-2):138-43. PubMed ID: 16675176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of particle size distribution on bioavailability of cyclosporine: novel drug delivery system.
    Andrýsek T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2001 Dec; 145(2):3-8. PubMed ID: 12426766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.
    El-Shabouri MH
    Int J Pharm; 2002 Dec; 249(1-2):101-8. PubMed ID: 12433438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding.
    Wu JZ; Ho PC
    Eur J Pharm Sci; 2006 Sep; 29(1):35-44. PubMed ID: 16824739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
    Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study.
    Mulik R; Mahadik K; Paradkar A
    Eur J Pharm Sci; 2009 Jun; 37(3-4):395-404. PubMed ID: 19491031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
    Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
    J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization.
    Jain S; Sharma RK; Vyas SP
    J Pharm Pharmacol; 2006 Mar; 58(3):303-10. PubMed ID: 16536896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang Z; Lv H; Zhou J
    Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polyelectrolyte nanoparticles with high drug loading enhance the oral uptake of hydrophobic compounds.
    Cheng WP; Gray AI; Tetley L; Hang Tle B; Schätzlein AG; Uchegbu IF
    Biomacromolecules; 2006 May; 7(5):1509-20. PubMed ID: 16677033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
    Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
    J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
    Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.